<i>BRAF</i> Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer.

Int J Breast Cancer · 2024 · PMC11199069 · PMID 38919805

Europe PMC DOI

hedged sentence

0.8880

closest p · 17.8× alpha

0.8880

boldest claim

The sentences

did not reach statistical significancep = 0.888not close (p > 0.1)

Among premenopausal patients, there was a trend towards greater survival in patients with BRAF high expression compared to those with low expression, though it did not reach statistical significance (median survival 282.57 vs. 228.1 months, respectively, p = 0.888, Figure 4(b) ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.